세계 수술용 이미징 시장 규모는 2024년 68억 달러에 달했습니다. 향후 IMARC Group은 이 시장이 2033년까지 107억 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 5.1%의 연평균 성장률(CAGR)을 기록할 것으로 전망하고 있습니다. 수술 건수 증가, 외과적 개입이 필요한 만성질환의 확대, 첨단 영상 기술을 갖춘 하이브리드 수술실의 보급 등이 시장을 주도하고 있습니다.
주요 시장 촉진요인 : 만성질환의 빈도 증가, 고급 진단, 외과적 개입의 필요성, 3D 이미징 및 휴대용 C-arm 장치를 갖춘 이미징 시스템의 기술 발전은 최소침습 수술에 대한 수요 증가에 대응하고 있습니다.
주요 시장 동향 : 수술용 이미징 시스템에서 인공지능(AI)과 머신러닝(ML)의 융합은 실시간 영상 분석을 간소화하여 외과 의사가 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다. 수술용 이미징 시장 개요에 따르면, 첨단 영상 처리 장비를 갖춘 하이브리드 수술실의 채택으로 복잡한 수술을 높은 정확도와 안전성으로 수행할 수 있게 됩니다.
지리적 동향 : 북미의 성장은 잘 구축된 의료 인프라, 높은 의료비, 첨단 기술의 급속한 도입에 기인합니다. 아시아태평양은 특히 중국, 인도 등의 국가에서 집단 의료 투자, 의료 관광의 부상, 의료 시설에 대한 접근성 강화로 인해 빠르게 성장하고 있습니다.
도전과 기회 : 고도의 영상처리 기술과 엄격한 규제 요건과 관련된 높은 비용으로 인해 저소득 지역에서의 활용을 제한하는 시장 개척에 어려움을 겪고 있습니다. 수술용 이미징 시장의 최근 비즈니스 기회는 수술용 이미징 시스템의 응용을 기존 분야에 국한하지 않고 스포츠 의학, 류마티스학 등의 분야로 확대하는 데에 있습니다.
외과 수술의 증가
수술용 이미징 시장 성장의 매우 중요한 기폭제가 되고 있는 것은 전 세계 외과 수술의 증가입니다. 의료 기술의 발전과 의료 서비스에 대한 접근성 증가로 인해 다양한 질병을 치료하기 위해 외과적 개입을 받는 사람들이 증가하고 있습니다. 예를 들어, 2023-24년 수술 건수는 2022-23년도에 기록했던 것보다 6,000건 가까이 더 많을 것으로 예상됩니다. 인공 고관절 및 인공 무릎관절 수술은 캐나다 서스캐처원 주에서 가장 많은 수술 중 하나입니다. 특히 고관절 및 슬관절 치환술의 연간 수술 건수는 전년도 6,300여 건에서 2023-2024년 7,100여 건으로 증가했습니다. 2023년 4월 1일부터 2024년 3월 31일까지 시행된 인공관절 치환술 규모는 2019-20년에 기록된 COVID-19 팬데믹 이전 연간 규모보다 50% 증가했으며, 2023년 4월 1일과 2024년 3월 31일에 9만 5,700건의 수술이 효율적으로 관리되어 역대 가장 많은 연간 수술 규모를 기록했습니다. 또한, 2024-2025년 예산에는 수술 능력 향상과 대기 시간 단축을 위해 228만 달러의 추가 투자가 이루어지고 있습니다. 따라서 헬스케어 조직의 확장은 외과 수술용 이미징 시장의 성장률 상승에 기여하고 있습니다.
만성질환의 유행
만성질환의 확산은 외과적 개입의 필요성을 크게 증가시킵니다. 심혈관질환, 암, 신경 질환 등의 치료에는 진단, 치료, 증상 관리를 위한 수술적 처치가 필요합니다. 생활습관의 변화, 인구의 고령화, 환경적 요인이 질병 부담에 기여함에 따라 만성질환의 발생률은 계속 증가하고 있습니다. 예를 들어, 2024년 1월 영국 심장 재단(BRITISH HEART FOUNDATION)에 따르면, 영국에서는 약 760만 명이 심장 및 순환기 질환을 앓고 있습니다. 이 숫자는 인구의 고령화와 심장 및 순환기 질환 후 생존율의 향상으로 인해 지속적으로 증가하고 있습니다. 또한, 남성 약 400만 명, 여성 약 360만 명이 심장 및 순환기 질환을 앓고 있는 것으로 나타났습니다. 영국 인구의 절반 이상이 일생 중 한 번 이상 심장 및 순환기 질환을 경험하게 될 것으로 예측됩니다. 주목할 만한 것은 심장 및 순환기 질환은 영국에서 연간 사망자 수의 약 27%를 차지하며, 17만 명 이상, 하루에 약 480명, 3분마다 1명이 사망하고 있다는 계산이 나옵니다. 또한, 심장 및 순환기계 질환은 영국에서 75세 미만에서 연간 4만 9,000명 가까이 목숨을 앗아가고 있습니다. 이 외에도 심혈관질환(CVD) 환자의 증가가 예상되기 때문에 수술용 이미징 시장의 수요는 앞으로도 계속 증가할 것으로 보입니다.
하이브리드 수술실 채용
하이브리드 수술실의 급속한 도입은 수술 환경에 첨단 영상 기술을 통합함으로써 외과 진료의 패러다임 전환을 상징합니다. 또한, 하이브리드 수술실은 기존의 수술 장비와 혈관조영장치, MRI 장치 등 최첨단 영상 시스템을 결합한 것입니다. 이를 통해 해부학적 구조와 수술 진행 상황을 실시간으로 시각화할 수 있어 수술의 정확성과 환자의 안전성을 높일 수 있습니다. 최소침습적 시술과 복잡한 수술에 대한 수요가 증가함에 따라 하이브리드 수술실 시설의 전 세계적 확산이 가속화되고 있습니다. 일례로, 2023년 세계 하이브리드 수술실 시장 규모는 11억 9,460만 달러에 달할 것으로 예상됩니다. 향후 IMARC Group은 하이브리드 수술실 시장이 2032년까지 27억 5,090만 달러에 달할 것으로 예상하며, 2024년부터 2032년까지 9.42%의 CAGR을 기록할 것으로 전망하고 있습니다. 하이브리드 수술실 시장은 기술 발전과 고급 외과적 개입에 대한 수요 증가로 인해 지속적으로 성장하고 있으며, 이는 수술용 이미징에 대한 좋은 시장 전망을 창출하고 있습니다.
The global surgical imaging market size reached USD 6.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is driven by the increasing number of surgical procedures, the expanding number of chronic ailments requiring surgical interventions, and the widespread adoption of hybrid operating rooms equipped with advanced imaging technologies are propelling the market growth.
Major Market Drivers: The growing frequency of chronic diseases, the need for advanced diagnostic, surgical interventions, and technological advancements in imaging systems with 3D imaging and portable C-arm devices accommodate to the growing demand for minimally invasive surgeries.
Key Market Trends: The union of artificial intelligence (AI) and machine learning (ML) in surgical imaging systems simplifies real-time imaging analytics, which supports surgeons in making informed decisions through procedures. As per the surgical imaging market overview, the adoption of hybrid operating rooms equipped with advanced imaging devices allows complex surgeries to be performed with high precision and safety.
Geographical Trends: The growth of North America is due to established healthcare infrastructure, elevated healthcare expenditure, and rapid adoption of advanced technologies. Also, the Asia-Pacific region is perceiving rapid growth owing to collective healthcare investments, emerging medical tourism, and intensifying access to healthcare facilities, particularly in countries such as China and India.
Competitive Landscape: Some of the surgical imaging companies include Canon Medical Systems Corporation, General Electric Company, Geonoray Co. Ltd., Hologic Inc., Koninklijke Philips N.V., Medtronic Plc, Primax International Srl, Prognosys Medical Systems Private Limited, Shimadzu Corporation, Siemens Aktiengesellschaft, Trivitron Healthcare Pvt. Ltd, Whale Imaging Inc., and Ziehm Imaging GmbH (Aton GmbH), among many others.
Challenges and Opportunities: The elevated costs linked with advanced imaging technologies and stringent regulatory requirements pose challenges to market development limiting availability in lower-income provinces. As per the surgical imaging market recent opportunities lie in the expansion of applications for surgical imaging systems beyond traditional fields into areas like sports medicine and rheumatology.
Increasing Surgical Procedures
The surgical procedures globally serve as a pivotal catalyst for the growth of the surgical imaging market. With advancements in medical technology and increasing access to healthcare services, more individuals are undergoing surgical interventions to address various medical conditions. For instance, in the fiscal year 2023-24, the number of surgeries performed exceeded the previous record set in 2022-23 by almost 6,000. There is a distinguished focus on hip and knee replacement surgeries, which rank among the highest-volume procedures in Saskatchewan, Canada. Explicitly, the annual volumes for hip and knee replacements rose from nearly 6,300 in the preceding year to almost 7,100 in 2023-2024. The size of joint substitute procedures conducted during this fiscal year April 1, 2023, to March 31, 2024, was 50% higher than the yearly size before the COVID-19 pandemic, recorded in 2019-20. On April 1, 2023, and March 31, 2024, 95,700 surgeries were efficiently supervised marking the most excessive annual surgical size ever documented. Also, the budget for 2024-2025 offers an additional investment of $2.28 million for increasing surgical capacities and diminishing wait times. Hence, the expanding healthcare organization contributes to the rise in surgical imaging market growth.
Prevalence of Chronic Diseases
The prevalence of chronic diseases significantly drives the need for surgical interventions. Conditions such as cardiovascular diseases, cancer, and neurological disorders require surgical procedures for diagnosis, treatment, or symptom management. As lifestyles change, populations age and environmental factors contribute to disease burden, the incidence of chronic illnesses continues to rise. For instance, as per the BRITISH HEART FOUNDATION in January 2024, in the UK, approximately 7.6 million individuals are afflicted with heart and circulatory diseases. This number is poised to increase due to an aging population and better survival rates following heart and circulatory incidents. It also reveals about 4 million men and 3.6 million women are affected by heart and circulatory diseases. It is projected that over half of the UK, population will experience a heart or circulatory disease at some point in their lives. Notably, heart and circulatory diseases are responsible for about 27% of all UK deaths annually, translating to more than 170,000 deaths or roughly 480 daily, amounting to one death every 3 minutes. Furthermore, heart and circulatory diseases claim nearly 49,000 lives under 75 years old annually in the UK. Besides this, the projected increase in cardiovascular disease (CVD) cases will continue to increase surgical imaging market demand.
Adoption of Hybrid Operating Rooms
The rapid adoption of hybrid operating rooms represents a paradigm shift in surgical practice, integrating advanced imaging technologies into surgical environments. Additonally, hybrid operating rooms combine traditional surgical equipment with state-of-the-art imaging systems such as angiography and MRI machines. It enables real-time visualization of anatomical structures and surgical progress, enhancing procedural accuracy and patient safety. The growing demand for minimally invasive procedures and complex interventions drives the expansion of hybrid operating room facilities worldwide. To state an instance, in 2023, the size of the global hybrid operating room market amounted to US$ 1,194.6 million. Moving ahead, IMARC Group anticipates the hybrid operating room market to achieve US$ 2,750.9 million by 2032, showcasing a compound annual growth rate (CAGR) of 9.42% from 2024 to 2032. As the hybrid operating room market continues to grow due to technological advancements and increasing demand for sophisticated surgical interventions it is creating a favorable surgical imaging market outlook.
Flat panel detector (FPD) accounts for the majority of the market share
Flat panel detectors (FPD) are highly favored in surgical imaging due to their superior image quality, lower radiation exposure, and greater durability compared to other imaging technologies. These detectors are extensively used in various surgical procedures, including orthopedic, cardiovascular, and neuro surgeries, driving their high adoption rate. For instance, on 6 July 2023, Shimadzu Medical Systems USA, a division of Shimadzu Corporation introduced the new V series Glass-Free Flat Panel Detectors (FPD), now integrated with general radiography platforms. These innovative glass-free FPD detectors feature a 99-micron pixel pitch for capturing highly detailed X-ray images. Additionally, their lightweight construction eases the workload on radiology technologists and increases durability against drops. It is available in three dimensions such as 17"x17", 14"x17", and 10"x12" that are compatible with RADspeed Pro style edition V series and MobileDaRt Evolution MX8 V type systems. Thus, FPD continues to dominate the market, due to the ongoing advancements and increasing demand for minimally invasive surgeries.
Mobile C-Arms are versatile imaging devices used extensively in operating rooms for a variety of diagnostic and interventional procedures. Their design allows for greater flexibility and mobility, making them ideal for surgeries requiring real-time imaging feedback such as orthopedics, cardiology, and vascular surgery. These systems provide high-resolution X-ray images, enabling precise placement of surgical instruments and implants. For instance, on 13 September 2023, Philips, a prominent leader in health technology, expanded its mobile C-arm lineup with the introduction of the Zenition 30, enhancing the capabilities of surgical teams by allowing surgeons more customization and autonomy in their use. It enhances the operational flexibility and customization for surgeons in C-arm usage and image capture, reducing the need for extensive technician assistance across various minimally invasive surgeries. The system is equipped with advanced imaging algorithms that ensure superior image quality and efficient dosage use. Thus, the demand for mobile C-Arms is increasing owing to their capability to facilitate quicker, more accurate surgical outcomes which is generating a surgical imaging market revenue.
Besides this, Mini C-Arms are compact, portable imaging devices specifically suited for extremity imaging, particularly in orthopedic and podiatric surgeries. These smaller versions of the traditional C-Arm are preferred for outpatient settings and smaller clinics due to their reduced size and ease of use. They are particularly valuable in sports medicine, pediatric applications, and intraoperative imaging where space and quick setup are crucial. Apart from this, mini C-Arms are also cost-effective, which makes them an attractive option for facilities with limited budgets or those that require a device dedicated to specific types of surgical procedures.
Orthopedic and trauma surgery represents the leading market segment
Orthopedic and trauma surgery is leading the market due to the increasing incidence of bone-related injuries and the rising demand for precise real-time imaging during complex orthopedic surgeries. Surgical imaging devices such as mobile C-arms have become essential in ensuring high accuracy and better outcomes in these procedures. The technological advancements in imaging technologies that offer enhanced image clarity and reduced exposure to radiation are further making them indispensable in today's orthopedic and trauma surgical practices, thus creating the surgical imaging market recent opportunities across the globe.
Hospitals exhibit a clear dominance in the market
Hospitals are driven by the high volume of complex surgeries, which necessitate advanced imaging technologies for accurate diagnostics and procedural guidance. It also has greater financial capabilities to invest in sophisticated surgical imaging systems compared to smaller clinics or diagnostic centers. Moreover, the push toward minimally invasive procedures, which require precise imaging for successful outcomes, further boosts the demand for high-end surgical imaging equipment within hospital settings. This trend is expected to continue as hospitals expand their technological capabilities to enhance surgical outcomes and patient care. Thus, in July 2021, the Government of Ontario allocated as much as $324 million to support Ontario's hospitals and community health sectors. This investment was designed to increase the capacity for more surgeries, MRI and CT scans, and other medical procedures, including during evenings and weekends. It is part of a broader, detailed plan aimed at improving surgical recovery and ensuring patients receive the necessary care. It allowed up to 67,000 extra surgeries and procedures. It provided up to 135,000 additional hours of diagnostic imaging which reduced wait times for medical procedures, enhanced access to healthcare services, and fulfilled the government's pledge to eliminate healthcare services in hallways.
North America leads the market, accounting for the largest surgical imaging market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical imaging.
The market in North America is leading due to advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and significant investments in research and development thus creating a positive surgical imaging market forecast. The region benefits from a robust regulatory framework that supports rapid approvals of innovative imaging technologies, facilitating their integration into surgical practices. For instance, in January 2024, Shimadzu Medical Systems USA, a branch of Shimadzu Corporation, achieved HCAI Special Seismic Certification preapproval for its FLUOROspeed X1 model. This certification confirms the system's ability to withstand earthquakes, enabling the deployment of this advanced patient-side conventional RF table system in California's healthcare settings. The FLUOROspeed X1, featuring patient-side table controls for easier operation, includes a 17"x17" dynamic digital X-ray detector (FPD) embedded in the table bucky, suitable for fluoroscopy and radiographic examinations. Its 31.5-inch gap between the tabletop and deck makes it an excellent digital RF system for imaging patients in wheelchairs and fits well in smaller spaces.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the surgical imaging industry include Canon Medical Systems Corporation, General Electric Company, Geonoray Co. Ltd., Hologic Inc., Koninklijke Philips N.V., Medtronic Plc, Primax International Srl, Prognosys Medical Systems Private Limited, Shimadzu Corporation, Siemens Aktiengesellschaft, Trivitron Healthcare Pvt. Ltd, Whale Imaging Inc., and Ziehm Imaging GmbH (Aton GmbH).
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
At present, the surgical imaging market recent developments by key players include innovation and expansion of product portfolios to meet the diverse needs of modern healthcare. These companies focus on developing advanced imaging technologies that offer clearer, more precise visuals to support complex surgical procedures. Many are also forging strategic partnerships and acquisitions to enhance their market reach and technological capabilities. Additionally, they invest heavily in research and development to introduce AI-driven and minimally invasive imaging solutions, aimed at improving patient outcomes and operational efficiency in hospitals and surgical centers. This strategic focus ensures their strong position in the competitive landscape. On 28 August 2022, Siemens Healthineers disclosed that the ARTIS icono ceiling, a ceiling-mounted angiography system, has received clearance from the Food and Drug Administration (FDA). This system is tailored to accommodate a broad spectrum of routine and advanced procedures in interventional radiology (IR) and cardiology. Moreover, its notable mechanical flexibility renders it applicable for various surgical interventions as well.
On 21 March 2024, Siemens Healthineers received approval from the Food and Drug Administration (FDA) for its CIARTIC Move, a mobile C-arm equipped with autonomous driving features. This system enhances the efficiency and standardization of 2D fluoroscopic imaging and 3D cone-beam CT scans for surgical teams in hospital and outpatient settings. By automating workflows, the CIARTIC Move streamlines the imaging process during surgeries, thereby improving consistency and reducing operation times. It is specifically designed for use in orthopedic, trauma, and spine surgeries and is adaptable for use in thoracic, vascular, cardiovascular, general surgeries, urology, and interventional pulmonology.
On 28 February 2024, Royal Philips, a prominent health technology company, introduced the Philips Image Guided Therapy Mobile C-arm System 9000 Zenition 90 Motorized. This new mobile C-arm is engineered to support surgeons in providing top-tier care to an increased number of patients. The system, enhanced to handle complex vascular conditions and various clinical operations such as cardiac procedures, pain management, and urology, is set to be commercially available starting in the second quarter of 2024. The automated processes enhance the flexibility and autonomy of surgeons, and intuitive motorization delivers enhanced control, while high-power (25 kW) capabilities support exceptional image quality, meeting the demands of complex vascular requirements and various clinical procedures.